Abstract: A storable biotransformation mixture that can oxidize a drug, comprising a cytochrome P450 enzyme, an electron donor; and, a buffer solution. In a preferred embodiment the mixture also contains liposomes, cytochrome b.sub.5 and NADPH-P450 reductase as the electron donor. The mixture is storable at a temperature less than 8.degree. C. to for at least two weeks and is able to oxidize a drug after storage.
Type:
Grant
Filed:
August 1, 1997
Date of Patent:
April 6, 1999
Assignee:
Panvera Corporation
Inventors:
Peter M. Shaw, Robert G. Lowery, David V. Thompson
Abstract: A homogeneous fluorescence-based nucleic acid detection and quantitation system is provided to measure nucleic acid in protein solutions. The process relies on the intercalation of a non-fluorescent dye into a double-stranded nucleic acid helix or single-stranded nucleic acid. The dye fluoresces after intercalation and the intensity is a direct measurement of the amount of nucleic acid present in the sample.
Type:
Grant
Filed:
April 2, 1996
Date of Patent:
October 20, 1998
Assignee:
PanVera Corporation
Inventors:
Thomas J. Burke, Randall E. Bolger, Francis J. Lenoch
Abstract: The present invention is based on the degradation of a fluorescence labeled nucleic acid such as DNA (F-DNA), RNA (F-RNA) or DNA/RNA substrate. The label may be covalently attached to the relatively high volume substrate at one position or many positions. The nucleic acid is then put in contact with another substance and activity is detected by Fluorescence Polarization.
Type:
Grant
Filed:
December 9, 1994
Date of Patent:
July 28, 1998
Assignee:
PanVera Corporation
Inventors:
Thomas J. Burke, Randall E. Bolger, William J. Checovich, David V. Thompson